A case of mediastinitis following botulinum toxin type A treatment for achalasia

Nature Clinical Practice Gastroenterology and Hepatology

Volumn 4, Issue 10, 2007, Pages 579-582

  Mac Iver, Robroy ^a   Liptay, Michael ^a   Johnson, Yolandra ^b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b Evanston Northwestern Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BOTULINUM TOXIN A; CIPROFLOXACIN; CLONAZEPAM; DIATRIZOATE; FLUCONAZOLE; GLIBENCLAMIDE; INSULIN; LEVOFLOXACIN; MIDAZOLAM; PANTOPRAZOLE; PETHIDINE; PIPERACILLIN PLUS TAZOBACTAM;

ADULT; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; DIABETIC RETINOPATHY; DIFFERENTIAL DIAGNOSIS; DYSPHAGIA; ESOPHAGITIS; ESOPHAGUS ACHALASIA; ESOPHAGUS DILATATION; ESOPHAGUS SPASM; ESOPHAGUS ULCER; FEMALE; FEVER; FOLLOW UP; GASTROESOPHAGEAL REFLUX; HUMAN; LOWER ESOPHAGUS SPHINCTER; MEDIASTINITIS; OBESITY; PLEURA EFFUSION; PLEURA FLUID; PRIORITY JOURNAL; SORE THROAT; THORACOTOMY; THORAX PAIN; TOTAL PARENTERAL NUTRITION; URINALYSIS; URINARY TRACT INFECTION; CHEMICALLY INDUCED DISORDER; ESOPHAGUS DISEASE; MIDDLE AGED; ULCER;

BOTULINUM TOXIN TYPE A; DIAGNOSIS, DIFFERENTIAL; ESOPHAGEAL ACHALASIA; ESOPHAGEAL DISEASES; FEMALE; HUMANS; MEDIASTINITIS; MIDDLE AGED; ULCER;

EID: 35448958806     PISSN: 17434378     EISSN: 17434386     Source Type: Journal    
DOI: 10.1038/ncpgasthep0951     Document Type: Article

References (12)

1. Eaker EY et al. (1997) Untoward effects of asophageal botulinum toxin injection in the treatment of achalasia. Dig Dis Sci 42 724-727
2. Tintillier M et al. (2004) Esophageal abscess complicating endoscopic treatment of refractory gastroesophageal reflux disease by Enteryx injection: A first case report. Am J Gastroenterol 99 1856-1858
3. Schuman BM et al. (1987) Complications of endoscopic injection sclerotherapy: A review. Am J Gastroenterol 82: 823-830
4. Fitzgerald JF et al. (2002) Clinical quiz. Sinus tract between esophagus and fundus. J Pediatr Gastroenterol Nutr 35: 38, 98
5. Andrews CN et al. (1999) Laparoscopic Heller's myotomy or botulinum toxin injection for management of esophageal achalasia. Patient choice and treatment outcomes. Surg Endosc 13: 742-746
6. Jankovic J and Brin MF (1991) Therapeutic uses of botulinum toxin. N Engl J Med 324: 1186-1194
7. Pasricha PJ et al. (1995) Intrasphincteric botulinum toxin for the treatment of achalasia. N Engl J Med 332: 774-778
8. Hurwitz M et al. (2000) Evaluation of the use of botulinum toxin in children with achalasia. J Pediatr Gastroenterol Nutr 30: 509-514
9. Kolbasnik J et al. (1999) Long-term efficacy of Botulinum toxin in classical achalasia: A prospective study. Am J Gastroenterol 94 3434-3439
10. D'Onofrio V et al. (2002) Long-term follow-up of achalasia patients treated with botulinum toxin. Dig Liver Dis 34: 105-110
11. Neubrand M et al. (2002) Long-term results and prognostic factors in the treatment of achalasia with botulinum toxin. Endoscopy 34: 519-523
12. Zaninotto G et al. (2004) Botulinum toxin injection versus laparoscopic myotomy for the treatment of esophageal achalasia: Economic analysis of a randomized trial. Surg Endosc 18: 691-695